Proposal of Modification for the Definition of Genetic Heterogeneity inHER2Testing in Breast Cancer-Reference-Cited by-同舟云学术

Proposal of Modification for the Definition of Genetic Heterogeneity inHER2Testing in Breast Cancer

Published:2010-02-01 Issue:2 Volume:134 Page:162-162
ISSN:1543-2165
Container-title:Archives of Pathology & Laboratory Medicine
language:en
Short-container-title:

Author:

Hsu Chih-Yi¹,Li Anna Fen-Yau¹,Yang Ching-Fen¹,Ho Donald Ming-Tak¹

Affiliation:

1. a Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 11217; Department of Pathology, National Yang-Ming University, School of Medicine, Taipei, Taiwan 11217

Publisher

Archives of Pathology and Laboratory Medicine

Subject

Medical Laboratory Technology,General Medicine,Pathology and Forensic Medicine

Link

http://meridian.allenpress.com/aplm/article-pdf/134/2/162/2768993/1543-2165-134_2_162_a.pdf

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 in situ hybridization test in breast cancer: quantifying margins of error and genetic heterogeneity;Modern Pathology;2021-05-12

2. ‘Genetic heterogeneity’ in HER2/neu testing by fluorescence in situ hybridization: a study of 2522 cases;Modern Pathology;2012-01-27

3. Frequency of HER2 Heterogeneity by Fluorescence In Situ Hybridization According to CAP Expert Panel Recommendations;American Journal of Clinical Pathology;2011-12-01

4. Genetic heterogeneity in HER2 testing may influence therapy eligibility;Breast Cancer Research and Treatment;2011-09-08

5. Relationship between pathological features, HER2 protein expression andHER2and CEP17 copy number in breast cancer: biological and methodological considerations;Journal of Clinical Pathology;2010-12-22